Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content
Woman in yoga class

About OsteoCool™ RF Ablation for Oncologists

   Indications, Safety, and Warnings

TOGETHER WE CAN TREAT CANCER PAIN IN NEW WAYS, SO PATIENTS CAN LIVE BETTER

OsteoCool™ Radiofrequency Ablation is a minimally invasive, palliative option for patients with bone tumors in the spine and in peripheral bone. Ablation times vary between 6.5 to 15 minutes per affected area.

Physicians can treat patients with OsteoCool right away, while other treatments, like radiation therapy, are being planned. Additionally, OsteoCool does not disrupt systemic therapies and it can be used before, during or after radiation therapy. If conventional cancer therapies are considered ineffective or too slow-acting, or if they cause unacceptable side effects,1 consider addressing your patient's cancer pain with the OsteoCool procedure.

COLLABORATION IN TREATMENT

PARTNERING TO ELEVATE THE GOLD STANDARD

Radiation therapy (RT) is the gold standard palliative treatment for patients with bone metastases. But there may be patients who cannot or do not benefit from RT as the only treatment for pain palliation.

Metastatic bone disease pain is multifaceted. While some pain derives from biological sources such as cytokine release, other pain sources are mechanical.2 We’re actively collaborating across specialties to find treatment algorithms that address the needs of patients with bone metastases.

Two doctors talking while walking through hospital.
QUESTIONS TO CONSIDER:
 
  • Based on your current protocol, how do you treat patients who have trouble receiving radiation due to pain? 
  • What are you doing to relieve pain for patients before they begin or during their radiation therapy?
  • Thinking about patients experiencing pain in your practice today, who might benefit from adjunctive RFA?
  • What measure do you take to treat pathologic fractures in your practice?

 

Download our Oncologist brochure

CASE DISCUSSION

  

Headshot of Dr. Tom Hopkins.

“It’s so important to identify new treatment opportunities and provide innovative therapies like OsteoCool to help us achieve positive outcomes with this patient population. At Duke, we have brought together a multidisciplinary team around spinal metastases management and have created a tumor board system which includes Interventionalists, Medical Oncology, Radiation Oncology, and Palliative Care. Each person comes to the table with their own thorough knowledge of how to treat this disease process. And, when you bring all of us together, we’ve found that we can do much more for these patients than we can independently." – Tom Hopkins, MD, Duke University School of Medicine, Durham, NC.

MULTIDISCIPLINARY CASE REVIEWS ON VUMEDI: TREATING BONE TUMORS WITH RADIOFREQUENCY ABLATION AND RADIATION THERAPY

Discover how Interventionalists and Oncologists work together to help patients suffering from Metastatic Bone Disease. The Medtronic Interventional Oncology VuMedi channel lets you learn at your leisure. Pre-recorded programs are now available for viewing. VuMedi is a public site that offers training and education to physicians on specific topics and is free to join and access.

View More Case Reviews on VuMedi

Patient Feature

Cory's Story

Cory’s breast cancer metastasized to her spine and sacrum causing unrelenting lower back pain that brought her into the ER. Not wanting to remain on opioids for her pain, Cory asked her doctor about other options. Dr. Ramsin Benyamin at Millennium Pain Center in Normal, IL offered to treat Cory’s cancer pain with OsteoCool.

Learn how the OsteoCool procedure affected Cory’s quality of life.

IMPORTANT SAFETY INFORMATION

INDICATIONS

  • Intended for palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a vertebral body
  • Coagulation and ablation of tissue in bone during surgical procedures including palliation of pain associated with metastatic lesions involving bone in patients who have failed or are not candidates for standard therapy
  • Ablation of benign bone tumors such as osteoid osteoma

RISKS

  • As a consequence of electrosurgery, damage to surrounding tissue through iatrogenic injury could occur
  • Pulmonary embolism

Contact us for more information

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center

1

Gangi et al. Image-Guided Ablation Therapy of Bone Tumors. Elsevier Inc, 2009.

2

Wallace AN, Greenwood TJ, Jennings JW. Radiofrequency ablation and vertebral augmentation for palliation of painful spinal metastases. J Neurooncol. 2015; 124(1); 15; 707-712.

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu

The views and opinions of the HCP expressed therein should be interpreted as personal views. They are completely independent and do not necessarily reflect the opinions of Medtronic.